Novartis International AG http://www.novartis.com <![CDATA[Novartis receives Complete Response letter from the US Food and Drug Administration for its investigational vaccine Menveo®]]> 2009-07-01T02:10:21 CET http://www.novartis.com/newsroom/media-releases/en/2009/1326284.shtml <![CDATA[Once-yearly Aclasta® approved in EU to treat osteoporosis caused by steroid treatment in men and postmenopausal women]]> 2009-06-26T07:15:00 CET http://www.novartis.com/newsroom/media-releases/en/2009/1325101.shtml <![CDATA[Sandoz receives approval for first-ever Japanese biosimilar]]> 2009-06-25T07:15:00 CET http://www.novartis.com/newsroom/media-releases/en/2009/1324821.shtml <![CDATA[Afinitor® and Sandostatin® LAR® Phase II data show advanced pancreatic NET patients remain progression-free for nearly 17 months]]> 2009-06-24T17:30:00 CET http://www.novartis.com/newsroom/media-releases/en/2009/1324661.shtml <![CDATA[New biological therapy Ilaris® approved in US to treat children and adults with CAPS, a serious life-long auto-inflammatory disease]]> 2009-06-18T07:15:00 CET http://www.novartis.com/newsroom/media-releases/en/2009/1323528.shtml <![CDATA[Novartis successfully demonstrates capabilities of cell-based technology for production of A(H1N1) vaccine]]> 2009-06-12T07:15:00 CET http://www.novartis.com/newsroom/media-releases/en/2009/1322241.shtml <![CDATA[Afinitor® Phase II data show positive results for patients with multiple types of lymphoma, leading to Phase III trial]]> 2009-06-08T07:15:00 CET http://www.novartis.com/newsroom/media-releases/en/2009/1320856.shtml <![CDATA[Tasigna® shows rapid and deep responses in newly diagnosed patients with a form of chronic myeloid leukemia]]> 2009-06-05T07:15:00 CET http://www.novartis.com/newsroom/media-releases/en/2009/1320149.shtml <![CDATA[Novartis announces typhoid vaccine research program in partnership with the Wellcome Trust]]> 2009-06-04T07:15:00 CET http://www.novartis.com/newsroom/media-releases/en/2009/1319838.shtml <![CDATA[One-year Phase III study confirms Ilaris® offers long-term remission in patients with CAPS, a severe lifelong auto-inflammatory disease]]> 2009-06-03T23:00:00 CET http://www.novartis.com/newsroom/media-releases/en/2009/1319771.shtml